ColoSeal™ ICD System Safety and Feasibility Study

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions
Colorectal Cancer
Interventions
DEVICE

ColoSeal ICD Device

The subject will undergo scheduled resection per the surgeon's preferred technique. Following completion of the anastomosis, the Intraluminal Colonic Diversion (ICD) Device will be inserted, advanced and positioned with the ICD Delivery System transanally. The ICD Device will remain in place for 10± 2 days. Anastomotic leak testing will be performed prior to scheduled removal.

Trial Locations (2)

0112

RECRUITING

Israeli-Georgian Medical Research Clinic Healthycore, Tbilisi

Unknown

RECRUITING

National Cancer Institute, Tashkent

Sponsors
All Listed Sponsors
lead

Averto Medical, Inc.

INDUSTRY